XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and can be Targeted to Overcome Chemoresistance - ...

Justin Taylor, M.D., a physician-scientist at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller ...

A University of Alberta research team has identified a DNA structure that activates the immune system in cancer cells that ...

The Utah father had been documenting his journey with cancer and the birth of his daughter after being first diagnosed at 25.

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...

Colon cancer is the second leading cause of cancer-related deaths ... may indicate a tumor obstructing the colon. Pain persisting beyond a few days, especially if severe or worsening, should be ...

After losing Henry McCann to colorectal cancer at the age of 25, "Because of Henry" advocates for early-onset patients who ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...

Tumors shrank more with the addition of acoustic cluster therapy to chemotherapy in colorectal liver metastases in the phase 1 ACTIVATE trial. Reflecting on my Son's Graduation as a Previvor. ...